NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001841

Registered date:02/04/2009

A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedParkinson disease
Date of first enrollment2009/04/01
Target sample size120
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Vitamin D3 placebo

Outcome(s)

Primary Outcomechanges of UPDRS, HY stage, MMSE
Secondary Outcomechanges of PDQ-39 and EQ-5D

Key inclusion & exclusion criteria

Age minimum45years-old
Age maximum85years-old
GenderMale and Female
Include criteria
Exclude criteria1. Already taking vitamin D supplement or 1,25 vitamin D 2. History of kidney stone 3. Familial or early onset (< 55 years old) type of Parkinson disease 4. Osteoporosis 5. Other difficulties judged by the physician in charge

Related Information

Contact

public contact
Name Emi Suzuki
Address Japan
Telephone
E-mail urashima@jikei.ac.jp
Affiliation Jikei University School of Medicine Division of Molecular Epidemiology
scientific contact
Name Mitsuyoshi Urashima
Address 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo 105-8461, Japan Japan
Telephone 03-3433-1111
E-mail
Affiliation Jikei University School of Medicine Division of Molecular Epidemiology